Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 2 , Pages 131-136 , March 2010

Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome

  • Joanne L. Thanavaro, DNP, ANP-BC, ACNP-BC, DCC

      Affiliations

    • St Louis University School of Nursing, St Louis, Missouri
    • Corresponding Author InformationReprint requests: Joanne L. Thanavaro, DNP, ANP-BC, ACNP-BC, DCC, St Louis University School of Nursing, 3525 Caroline Avenue, Room 321, St Louis, MO 63104.
    • ,
  • Samer Thanavaro, MD, FACC

      Affiliations

    • Christian Northeast Hospital, St Louis, Missouri

References 

  1. Pappone C, Santinelli V, Rosanio S, Vicedomini G, Nardi S, Pappone A, et al. Usefulness of invasive electrophysiology testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern. Results from a large prospective long-term follow-up study. J Am Coll Cardiol. 2003;41:239–244
  2. Priori SG, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P, et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J. 2001;22:1374–1450
  3. Fengler B, Brady W, Plautz C. Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED. Am J Emerg Med. 2007;25:476–583
  4. Ray IB. Wide complex tachycardia: recognition and management in the emergency room. J Assoc Physicians India. 2004;52:882–887
  5. Chew H, Lim S. Broad complex atrial fibrillation. Am J Emerg Med. 2007;25:459–463
  6. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:e247–e346
  7. Rosner M, Brady W, Kefer M, Martin M. Electrocardiography in the patient with the Wolff-Parkinson-White syndrome: diagnostic and initial therapeutic issues. Am J Emerg Med. 1999;17:705–714
  8. Miller J. Therapy of Wolff-Parkinson-White syndrome and concealed bypass tracts: Part I. J Cardiovasc Electrophysiol. 1996;7:85–89
  9. Mash K. Wolff-Parkinson-White: assessing and treating asymptomatic patients. Br J Cardiac Nurs. 2007;2:176–181
  10. Fox DJ, Klein GJ, Skanes C, Gula LJ, Yee R, Krahn AD, et al. How to identify the location of an accessory pathway by the 12-lead ECG. Heart Rhythm. 2008;5:1763–1766
  11. Centurion O, Shimizu A, Isomoto S, Konoe A. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway. Europace. 2008;10:294–302
  12. Fujimura O, Klein G, Yee R, Sharma A. Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway?. J Am Coll Cardiol. 1990;15:1082–1086
  13. Munger TM, Packer DL, Hammill SC, Feldman BJ, Bailey KR, Ballard DJ, et al. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted County, Minnesota 1953–1989. Circulation. 1993;87:866–873
  14. Sethi K, Dhali A, Chadha D, Garg S, Malani S, Mathew O. WPW and preexcitation syndrome. J Assoc Physicians India. 2007;55:10–15
  15. Marine J. Catheter ablation therapy for supraventricular arrhythmias. JAMA. 2007;298:2768–2778
  16. Della Bella P, Brugada P, Talajic M, Lemery R, Torner P, Lezaun R, et al. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway. J Am Coll Cardiol. 1991;17:1352–1356
  17. Gaita F, Giustetto C, Riccardi R, Mazza A, Mangiardi L, Rosettani E, et al. Relation between spontaneous atrial fibrillation and atrial vulnerability in patients with Wolff-Parkinson-White pattern. Pacing Clin Electrophysiol. 1990;13:1249–1253
  18. Riccardi R, Gaita F, Giustetto C, Gardiol S. Atrial electrophysiologic features in patients with Wolff-Parkinson-White and atrial fibrillation; Absence of rate adaptation of intraatrial conduction time parameters. Pacing Clin Electrophysiol. 1997;20:1318–1327
  19. Jackman W, Yeung-Lai-Wah J, Friday K, Khan A, Sakurai M, Lazzara R. Tachycardia originating in accessory pathway networks mimicking atrial flutter and fibrillation (abstract). J Am Coll Cardiol. 1986;7:6A
  20. Oddsson H, Edvardsson N, Walfridsson H. Episodes of atrial fibrillation and atrial vulnerability after successful radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome. Europace. 2002;4:201–206
  21. Harmada T, Hiraki T, Kabara I, Ohga M, Imaizumi T. Mechanisms for atrial fibrillation in patients with Wolff-Parkinson-White syndrome. J Cardiovac Electrophysiol. 2002;13:223–229
  22. Wathen M, Natale A, Wolfe K, Yee R, Klein G. Initiation of atrial fibrillation in the Wolff-Parkinson-White syndrome: importance of the accessory pathway. Am Heart J. 1993;125:753–759
  23. Todd D, Klein G, Krahn A, Skanes A, Yee R. Asymptomatic Wolff-Parkinson-White syndrome: is it time to visit guidelines. Am J Cardiol. 2003;41:245–28
  24. Blomström-Lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias. Circulation. 2003;108:1871–1909
  25. Weng K, Wolff G, Young M. Multiple accessory pathways in pediatric patients with Wolff-Parkinson-White syndrome. Am J Cardiol. 2003;91:1178–1183
  26. Brembilla-Perrot B, Chometon F, Groben L, Tatar C, Luporsi JD, Bertrand J, et al. Are the results of electrophysiological study different in patients with a pre-excitation syndrome, with and without syncope. Europace. 2008;10:175–180
  27. Fananapazir L, German D, Gallagher J, Lowe J, Prystowsky E. Importance of preexcited QRS morphology during induced atrial fibrillation to the diagnosis and localization of multiple accessory pathways. Circulation. 1990;81:578–585
  28. Gupta A, Shah C, Maheshwari A, Thakur R, Hayes O, Lokhandwala Y. Adenosine induced ventricular fibrillation in Wolff-Parkinson-White Syndrome. Pacing Clin Electrophysiol. 2002;25:477–480
  29. Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2006;48:e149–e246
  30. Dagres N, Clague J, Lottkamp H, Hindricks G, Breithardt G, Borggrefe M. Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up: high recurrence rate of atrial fibrillation in patients older than 50 years of age. Eur Heart J. 2001;22:423–427
  31. Timmermans C, Smeets J, Rodriguez L, Vrouchos G, van den Dool A, Wellens H. Aborted sudden death in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1995;76:492–494

PII: S0147-9563(09)00161-7

doi: 10.1016/j.hrtlng.2009.06.011

Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 2 , Pages 131-136 , March 2010

Article Tools

* Image Usage & Resolution